Onderneming NeuroOne Medical Technologies Corporation Other OTC
Aandelen
NMTC
US64130M1009
Geavanceerde medische apparatuur & technologie
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Strip/Grid Products, Stereoelectrocencephalography Products and Electrode Cable Assembly Products
57,3
%
| 0 | 8,1 % | 2 | 57,3 % | +1.040,65% |
Collaborations
42,7
%
| 2 | 91,9 % | 1 | 42,7 % | -25,33% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 | 100,0 % | 3 | 100,0 % | +60,73% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mark Christanson
FOU | Founder | 56 | 20-08-09 |
David Rosa
CEO | Chief Executive Officer | 59 | 20-07-17 |
Ronald McClurg
DFI | Director of Finance/CFO | 65 | 01-01-21 |
Chief Operating Officer | 53 | 10/11 | |
Steven Mertens
CTO | Chief Tech/Sci/R&D Officer | 61 | 15-04-19 |
Chad Wilhelmy
LAW | General Counsel | - | 18-01-22 |
Hijaz Haris
SAM | Sales & Marketing | - | 27-04-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Paul Buckman
CHM | Chairman | 68 | 04-08-17 |
Director/Board Member | 63 | 04-08-17 | |
Edward Andrle
BRD | Director/Board Member | 66 | 18-02-20 |
David Rosa
CEO | Chief Executive Officer | 59 | 20-07-17 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 27 515 921 | 24 381 601 ( 88,61 %) | 0 | 88,61 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
-24,07% | 17,02 mld. | |
-42,47% | 2,84 mld. | |
+13,40% | 1,8 mld. | |
-10,21% | 1,5 mld. | |
+32,69% | 1,33 mld. | |
-21,01% | 911 mln. | |
-25,79% | 849 mln. | |
+5,15% | 824 mln. | |
-27,85% | 604 mln. |